ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health Eli Lilly and Company
Tyche Wealth Partners LLC Sells 2,015 Shares of Eli Lilly and Company $LLY MarketBeat
Lilly says Foundayo pill lowers heart attack, stroke risk in study Reuters
Lilly vows to join state in development of nuclear energy solutions WTHR
Lilly’s new obesity pill passes heart safety test in diabetes BioPharma Dive
Eli Lilly and Company (LLY) Price Target Increased At Morgan Stanley on Updated Biopharma Model Assumptions Yahoo Finance
Braun signs nuclear energy-related letter of intent with Eli Lilly and Company Fox 59
Gov. Braun signs Nuclear Energy Letter of Intent with Eli Lilly and Company giant.fm
The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust The Motley Fool
Braun administration, Eli Lilly to collaborate on nuclear power development Indianapolis Business Journal
Guggenheim reiterates Eli Lilly stock rating on positive trial data Investing.com
Eli Lilly acquires Houston biotech startup for $300M Houston Chronicle
Eli Lilly and Company $LLY Shares Acquired by Farther Finance Advisors LLC MarketBeat
US appeals court revives Teva lawsuit against Eli Lilly over migraine drug Reuters
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions Eli Lilly and Company
Oak Ridge Investments LLC Buys 4,934 Shares of Eli Lilly and Company $LLY MarketBeat
Eli Lilly and Company $LLY Shares Acquired by Freestone Capital Holdings LLC MarketBeat
Eli Lilly and Company (NYSE:LLY) Stock Price Up 2.5% - Time to Buy? MarketBeat
Eli Lilly and Company $LLY Shares Sold by Altfest L J & Co. Inc. MarketBeat
Hedeker Wealth LLC Has $9.73 Million Stock Holdings in Eli Lilly and Company $LLY MarketBeat
Eli Lilly and Company $LLY Shares Acquired by Stanley Laman Group Ltd. MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 102,900 Shares of Eli Lilly and Company $LLY MarketBeat
Greenup Street Wealth Management LLC Takes Position in Eli Lilly and Company $LLY MarketBeat
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders PR Newswire
Eli Lilly stock pops after FDA approves new GLP-1 weight-loss pill Yahoo Finance
Market Street Wealth Management Advisors LLC Has $18.14 Million Stock Position in Eli Lilly and Company $LLY MarketBeat
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson Benzinga
Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal statnews.com
Gov. Mike Braun Signs Nuclear Energy Letter Of Intent With Eli Lilly And Company InkFreeNews.com
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market CNBC
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes Eli Lilly and Company
Eli Lilly and the ‘societal obligation’ of GLP-1s statnews.com
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India CNBC
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook Yahoo Finance
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk statnews.com
FDA grants speedy approval to Eli Lilly’s weight-loss pill for obesity AP News
Jim Cramer Believes Eli Lilly’s “Weight Loss Pill Will Be a Blockbuster” Yahoo Finance
Eli Lilly Going Nuclear WIBC 93.1 FM
FDA approves GLP-1 weight loss pill Foundayo from Eli Lilly NBC News
Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility Eli Lilly and Company